NCT01375868View on ClinicalTrials.gov

Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Squamous Papilloma of the Larynx
Interventions
BIOLOGICAL

Silgard

vaccination with tetravalent antiviral vaccine

Trial Locations (1)

128 20

Institute of Hematology and Blood Transfusion, Prague

All Listed Sponsors
collaborator

Medical Healthcom Prague

UNKNOWN

collaborator

Na Homolce Hospital

OTHER

lead

Ruth Tachezy, PhD.

OTHER

NCT01375868 - Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis | Biotech Hunter | Biotech Hunter